Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.
Inceptive
5 followers
Mineralys Therapeutics
3 followers
Othram
3 followers
Slingshot Biosciences
3 followers
Enveda Biosciences
2 followers
Acepodia
2 followers
Generate Biomedicines
5 followers
Ansa Biotechnologies
1 follower
Kriya Therapeutics
3 followers
Manifold Bio
3 followers
Artiva Biotherapeutics
2 followers
MBX Biosciences
2 followers